Rep. Carter's Fight Against Predatory Drug Pricing Leads FTC to Launch Inquiry
June 08, 2022
June 08, 2022
WASHINGTON, June 8 -- Rep. Buddy Carter, R-Georgia, issued the following news release on June 7, 2022:
In a major win for patients, the Federal Trade Commission (FTC) today unanimously approved to launch an inquiry examining pharmacy benefit managers' (PBMs) unfair and deceptive business practices.
This announcement comes after years of advocacy from Rep. Buddy Carter (R-GA), a pharmacist by trade, who recently wrote a letter to the FTC calling for an investigation . . .
In a major win for patients, the Federal Trade Commission (FTC) today unanimously approved to launch an inquiry examining pharmacy benefit managers' (PBMs) unfair and deceptive business practices.
This announcement comes after years of advocacy from Rep. Buddy Carter (R-GA), a pharmacist by trade, who recently wrote a letter to the FTC calling for an investigation . . .